Australia markets closed

iTeos Therapeutics, Inc. (ITOS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.66+0.17 (+1.48%)
At close: 04:00PM EDT
11.66 0.00 (0.00%)
After hours: 04:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 419.36M
Enterprise value -106.50M
Trailing P/E 2.46
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)33.11
Price/book (mrq)0.73
Enterprise value/revenue -8.46
Enterprise value/EBITDA 0.74

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3-18.45%
S&P500 52-week change 322.38%
52-week high 318.24
52-week low 38.20
50-day moving average 311.45
200-day moving average 311.11

Share statistics

Avg vol (3-month) 3286.52k
Avg vol (10-day) 3301.71k
Shares outstanding 535.97M
Implied shares outstanding 635.97M
Float 824.82M
% held by insiders 10.54%
% held by institutions 1102.03%
Shares short (15 Apr 2024) 42.12M
Short ratio (15 Apr 2024) 47.27
Short % of float (15 Apr 2024) 410.51%
Short % of shares outstanding (15 Apr 2024) 45.92%
Shares short (prior month 15 Mar 2024) 42.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,171.69%

Management effectiveness

Return on assets (ttm)-12.97%
Return on equity (ttm)-18.19%

Income statement

Revenue (ttm)12.6M
Revenue per share (ttm)0.35
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -146.68M
Net income avi to common (ttm)-112.64M
Diluted EPS (ttm)-3.15
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)531.92M
Total cash per share (mrq)14.84
Total debt (mrq)6.06M
Total debt/equity (mrq)1.05%
Current ratio (mrq)13.76
Book value per share (mrq)16.05

Cash flow statement

Operating cash flow (ttm)-103.76M
Levered free cash flow (ttm)-73.28M